UBS Group
CL icon

UBS Group’s Colgate-Palmolive CL Stock Holding History

UBS Group’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$393M Buy
4,614,605
+63,913
+1% +$5.7M 0.06% 336
2025
Q4 		$360M Sell
4,550,692
-1,338,323
-23% -$105M 0.06% 329
2025
Q3 		$471M Buy
5,889,015
+1,493,158
+34% +$127M 0.07% 250
2025
Q2 		$400M Sell
4,395,857
-746,423
-15% -$68.1M 0.07% 276
2025
Q1 		$482M Buy
5,142,280
+700,788
+16% +$62.7M 0.09% 221
2024
Q4 		$404M Buy
4,441,492
+102,092
+2% +$9.74M 0.07% 249
2024
Q3 		$450M Buy
4,339,400
+20,596
+0.5% +$2.1M 0.1% 192
2024
Q2 		$419M Buy
4,318,804
+138,035
+3% +$12.7M 0.1% 189
2024
Q1 		$376M Buy
4,180,769
+1,187,245
+40% +$101M 0.09% 207
2023
Q4 		$239M Sell
2,993,524
-454,755
-13% -$34.2M 0.07% 287
2023
Q3 		$245M Sell
3,448,279
-37,707
-1% -$2.82M 0.08% 240
2023
Q2 		$269M Buy
3,485,986
+660,112
+23% +$51.1M 0.09% 224
2023
Q1 		$212M Sell
2,825,874
-121,445
-4% -$9.03M 0.08% 240
2022
Q4 		$232M Buy
2,947,319
+250,478
+9% +$18.8M 0.09% 241
2022
Q3 		$189M Sell
2,696,841
-452,713
-14% -$35.5M 0.08% 249
2022
Q2 		$252M Sell
3,149,554
-292,463
-8% -$22.9M 0.1% 209
2022
Q1 		$261M Buy
3,442,017
+17,138
+0.5% +$1.36M 0.09% 240
2021
Q4 		$292M Buy
3,424,879
+90,306
+3% +$7.05M 0.08% 240
2021
Q3 		$252M Sell
3,334,573
-280,138
-8% -$22.2M 0.08% 252
2021
Q2 		$294M Buy
3,614,711
+476,558
+15% +$39M 0.09% 212
2021
Q1 		$247M Sell
3,138,153
-214,064
-6% -$16.8M 0.08% 246
2020
Q4 		$287M Sell
3,352,217
-612,689
-15% -$50.7M 0.1% 224
2020
Q3 		$306M Buy
3,964,906
+416,374
+12% +$31.7M 0.12% 183
2020
Q2 		$260M Buy
3,548,532
+250,887
+8% +$17.8M 0.11% 196
2020
Q1 		$219M Buy
3,297,645
+180,233
+6% +$12.7M 0.1% 196
2019
Q4 		$215M Sell
3,117,412
-96,718
-3% -$6.59M 0.07% 253
2019
Q3 		$236M Sell
3,214,130
-144,734
-4% -$10.5M 0.09% 220
2019
Q2 		$241M Buy
3,358,864
+156,168
+5% +$11.1M 0.09% 209
2019
Q1 		$220M Sell
3,202,696
-730,714
-19% -$47.2M 0.09% 210
2018
Q4 		$234M Sell
3,933,410
-10,629,100
-73% -$665M 0.11% 201
2018
Q3 		$975M Buy
14,562,510
+1,715,869
+13% +$114M 0.39% 52
2018
Q2 		$833M Sell
12,846,641
-785,459
-6% -$51.4M 0.36% 52
2018
Q1 		$977M Buy
13,632,100
+939,944
+7% +$67.6M 0.42% 41
2017
Q4 		$958M Buy
12,692,156
+2,036,321
+19% +$149M 0.39% 44
2017
Q3 		$776M Sell
10,655,835
-622,204
-6% -$44.8M 0.36% 52
2017
Q2 		$836M Buy
11,278,039
+509,445
+5% +$37.8M 0.43% 40
2017
Q1 		$788M Buy
10,768,594
+721,181
+7% +$50.5M 0.43% 38
2016
Q4 		$658M Buy
10,047,413
+194,483
+2% +$13.3M 0.36% 47
2016
Q3 		$730M Buy
9,852,930
+296,808
+3% +$21.9M 0.44% 36
2016
Q2 		$700M Buy
9,556,122
+240,457
+3% +$17.1M 0.44% 31
2016
Q1 		$658M Sell
9,315,665
-61,975
-0.7% -$4.12M 0.44% 31
2015
Q4 		$625M Buy
9,377,640
+100,897
+1% +$6.71M 0.41% 35
2015
Q3 		$589M Buy
9,276,743
+185,436
+2% +$12.1M 0.42% 28
2015
Q2 		$595M Buy
9,091,307
+432,344
+5% +$29.3M 0.4% 31
2015
Q1 		$600M Buy
8,658,963
+318,391
+4% +$22M 0.41% 33
2014
Q4 		$577M Buy
+8,340,572
New +$563M 0.4% 37

Other funds holding CL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

UBS Group's CL Position: Q1 2026 in Review

UBS Group increased its Colgate-Palmolive (CL) stake by 1.4% in Q1 2026, buying an estimated $5.7M and bringing the position to 4,614,605 shares worth $393M. The position accounts for 0.06% of the portfolio, ranked #336.

UBS Group first reported a position in CL in Q4 2014 and has held it in 46 quarters since. The position peaked at $977M in Q1 2018. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • UBS Group held 4,614,605 shares of Colgate-Palmolive worth $393M as of Q1 2026.
  • UBS Group bought 63,913 Colgate-Palmolive shares in Q1 2026, an estimated $5.7M.
  • Colgate-Palmolive made up 0.06% of UBS Group's portfolio in Q1 2026, its #336 holding.
  • UBS Group first reported a position in Colgate-Palmolive in Q4 2014 and has held it in 46 quarters since.
  • UBS Group's Colgate-Palmolive position peaked at $977M in Q1 2018.
  • 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.